// App-Quantinova.ai

PD4-2 : Cardiovascular toxicity following aromatase inhibitor use in 13,273 survivors cared for in a HMO

Researchers

Presenter

  • Haque R

Principal Investigators

  • Schottinger JE

  • Shi JChung JAvila C

  • Amundsen B

  • Chlebowski RT

Medical Centers

  • Kaiser Permanente Southern California, Duarte, CA

  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Congestive heart failure

  • Heart muscle disease

  • Breast cancer

  • Hypertension

  • Pericarditis

  • Diabetes

  • Angina

  • Solid malignancies

  • Stroke

Biomarkers

  • Stromal interaction molecule 1

Drug/Treatment

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved